Myrbetriq (mirabegron)

pCPA File Number: 20837
Negotiation Status:
Concluded with an LOI
Indication(s):
Overactive Bladder
Sponsor/Manufacturer:
Astellas Pharma Inc.
CDA-AMC Project Number:
SR0363-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: